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Abstract 
 
Purpose— Advanced hemodynamic monitoring in cardiac surgery translates into 
improvement in outcomes. We evaluated the relationship between central venous (ScvO2) 
and mixed venous (SvO2) saturations over the early postoperative period. The adequacy 
of their interchangeability was tested in patients with varying degrees of cardiac 
performance. 
Methods— In this prospective observational study we evaluated 156 consecutive cardiac 
surgical patients in an academic center. ScvO2 and SvO2 data were harvested from 468 
paired samples taken preoperatively (T0), after weaning from cardiopulmonary bypass 
(CPB, T1) and on postoperative day 1 (T2).  
Results—The relationship between ScvO2 and SvO2 was inconsistent, with inferior 
correlations in patients with lower cardiac indices (CI), (Pearson’s r
2
=0.37 if CI≤2.0 
L/min/m
2
 vs. r
2
=0.73 if CI>2.0 L/min/m
2
, both P<0.01). Patients with lower CI also had 
wider 95% limits of agreement between SvO2 and ScvO2. The proportion of patients with 
a negative SvO2–ScvO2 gradient increased over time (48/156 (31%) at T0 to 73/156 
(47%) at T2, P<0.01). This subgroup more frequently required inotropes at T2 than 
patients with a positive SvO2–ScvO2 gradient (odds ratio 6.46 [95% CI 0.81-51.87], 
P=0.06), and also had higher serum lactate levels (1.5±0.8 vs. 1.0±0.4, P<0.01).  
Conclusions— The diagnostic accuracy of ScvO2 for estimating SvO2 is proportional to 
cardiac performance. A negative SvO2–ScvO2 gradient at T2 correlated with inotropic 
support requirement, higher operative risk score, age, lactate level and duration of CPB.  
Key words: mixed venous saturation, central venous saturation, pulmonary artery 
catheter, cardiac surgery 
  
1. Introduction 
 
Global tissue hypoxia portends poor outcomes. Detection and prompt intervention 
designed to counter its effects are paramount in optimizing patient outcomes.  
Pulmonary artery catheters (PACs) have historically been the mainstay of hemodynamic 
monitoring [1]. PACs provide left and right-sided filling pressures [1]. While filling 
pressures are suboptimal correlates of the volume status, they are often used to guide 
fluid resuscitation [2]. Moreover, pulmonary capillary wedge pressure has been found to 
be a predictor of adverse outcomes following acute myocardial infarction [3,4]. In the 
contemporary cardiac surgical arena the PAC provides important information about the 
hemodynamic performance of the right ventricle and the resistance in the pulmonary 
vascular bed. The former is relevant in identifying candidates for long-term left 
ventricular mechanical circulatory assistance, while the latter is invaluable in evaluating 
cardiac transplant candidacy. The potential benefits of PACs notwithstanding, there is 
substantial evidence to support their inefficiency in reducing mortality in both intensive 
care unit (ICU) and high-risk surgical patients [5]. Furthermore, PAC insertion is an 
invasive procedure, which requires manipulation of the catheter across the tricuspid and 
pulmonary valves. The incidence of complications is low, and these are mainly related to 
line insertion [6]. Unselective PAC insertion to all cardiac surgical patients has been 
found to be deleterious among patients undergoing isolated coronary artery bypass 
grafting [7].  
The widespread use of central venous catheters in the ICU makes the acquisition of 
central venous saturations (ScvO2) simple and inexpensive. Despite the considerable 
investigational effort that has been spent on evaluating the relationship between ScvO2 
and mixed venous saturation (SvO2), the controversy surrounding their interchangeability 
remains unresolved [8]. While they are clearly interlinked, the former is also dependent 
on oxygen content in the splanchnic and coronary circulations. The low oxygen 
extraction from the kidneys may account for high venous saturation in the inferior vena 
cava (IVC). Conversely, the very low oxygen content from the coronary sinus mirrors the 
highly efficient oxygen utilization in the heart. During hypoperfusion blood may be 
diverted away from the splanchnic circulation while oxygen demand may increase. Both 
of these events could result in lower saturation in the IVC, and therefore lead to a 
negative SvO2-ScvO2 gradient. 
Our study aimed to explore the correlation between SvO2 and ScvO2 under both optimal 
hemodynamic settings and during low cardiac output among cardiac surgical patients. We 
hypothesized that the diagnostic accuracy of ScvO2 in predicting SvO2 would be 
compromised in the setting of inferior myocardial performance. Furthermore, we 
investigated the dynamics of the relationship between SvO2 and ScvO2 over the 
immediate perioperative period.  
 
 
 
 
 
 
  
2. Materials and methods 
2.1. Setting 
We evaluated patients undergoing cardiac surgery at a single academic center in Croatia 
(University Hospital Center Zagreb). Upon completion of the surgical procedure patients 
were transferred to a dedicated surgical intensive care unit. The study was approved by 
the Ethics committee of the University Hospital Center Zagreb. Ethical standards in line 
with the Declaration of Helsinki were adhered to. Written informed consent was obtained 
from all patients prior to enrollment. 
 
2.2. Study population 
Patient enrollment for this observational cohort study commenced in April 2013 and was 
completed in July 2013. All consecutive patients undergoing cardiac surgery with the use 
of CPB for acquired heart disease were evaluated for eligibility. Exclusion criteria 
included congenital pathology, emergent cases, heart transplantation, off-pump coronary 
artery bypass grafting and inability to provide consent. Additionally, patients requiring 
mechanical circulatory assistance were also excluded, as their impact on group 
homogeneity would have been profound. 
 
2.3. Hemodynamic monitoring 
The standard monitoring protocol in our study included a pulmonary artery catheter 
(Argon Medical Devices, Singapore), which was almost universally inserted via the right 
jugular vein. We relied on pressure tracings for the correct positioning of PACs. 
Thermodilution cardiac indices and other hemodynamic data were obtained in triplicate 
and then averaged. An additional central venous line was placed through either a jugular 
or subclavian vein. Continuous arterial monitoring was typically performed via a right 
radial catheter. One of the femoral arteries was used for arterial access in the unlikely 
event that the radial arterial route was inadequate.  
 
2.4. Measurement of mixed venous and central venous saturations 
Samples used for determining SvO2 and ScvO2 were drawn simultaneously from the 
distal port of the PAC and a separately placed central venous line, respectively. They 
were subjected to a blood gas analysis without delay. The blood gas analyzer (RAPIDlab 
1265, Siemens, Germany) was calibrated on a daily basis. Blood sampling was performed 
after induction of anesthesia (T0), immediately upon weaning from CPB (T1) and on 
postoperative day 1 (T2).  
 
2.5. Cardiopulmonary bypass and perioperative management 
The anesthetic regime included induction and maintenance of anesthesia with midazolam, 
fentanyl and pancuronium bromide. This was coupled with sevoflurane inhalation. The 
initial ventilator settings included a tidal volume of 8 ml/kg, and a respiratory rate of 12 
breaths per minute. Typically, the FiO2 was set at 50%. The ascending aorta and right 
atrium were cannulated for CPB. Myocardial protection consisted of both antegrade and 
retrograde cardioplegia. Systemic heparinization aiming at an ACT > 480 seconds was 
used, followed by full reversal with protamine after decannulation. A CPB flow of greater 
than 2.0 L/min/m
2
 was targeted. The target mean arterial pressure during CPB was 60-70 
mmHg. If necessary, norepinephrine was employed to reach the aimed blood pressure. 
The lungs were open to atmosphere during CPB. Weaning from CPB was initiated once 
the patient’s rhythm had been stabilized and the patient was re-warmed and de-aired. We 
universally followed a goal-oriented strategy targeting a cardiac index of greater than 2.0 
L/min/m2 for the entire duration of postoperative hemodynamic monitoring. Active 
interventions to achieve that goal included volume replacement and inotropic support. 
The preferred inotropic agent was dobutamine, but milrinone, epinephrine and 
levosimendan were used sporadically. A further upgrade of hemodynamic support in 
patients resistant to the aforementioned interventions included extracorporeal membrane 
oxygenation (ECMO). One patient in whom ECMO support was employed 
postoperatively was excluded from the study, due to the fact that PAC data is difficult to 
interpret this setting.  
 
2.6. Statistical analysis 
The continuous data are presented as mean values ± standard deviation or medians with 
their respective interquartile range. Categorical variables are shown as absolute numbers 
with percentages. Continuous data between different groups were compared with the 
Mann-Whitney U-test. Differences between categorical variables were evaluated with 
Fisher’s exact test. A two-tailed P-value <0.05 was considered to be significant. Pearson 
product-moment correlation coefficients (r) were used to explore the relationships 
between continuous data. The comparisons between ScvO2 and SvO2 also included a 
mean bias and 95% limits of agreement in line with a Bland-Altman analysis. 
Furthermore, the diagnostic accuracy of ScvO2 for predicting SvO2 was assessed under 
different hemodynamic conditions. Venous saturation data harvested from patients with a 
CI≤2.0 L/min/m
2
 were compared to data taken from patients with a CI>2.0 L/min/m
2
. In 
order to minimize bias and to account for different sample sizes between these datasets, a 
1:1 propensity score matching was performed. The covariates used in the matching 
process were age, operative risk score (EuroSCORE 2), duration of CPB, use of inotropic 
agents, and serum lactate concentrations at the time of sample acquisition. The data were 
processed using the IBM SPSS 22.0 software package (Somers, New York, USA). 
 
  
3. Results 
3.1. Study participants 
A total of 156 non-emergent consecutive patients undergoing cardiac surgery with the use 
of CPB were included in this prospective observational study. Venous saturation data 
were harvested from 468 paired samples acquired at 3 predetermined time-points. The 
median ICU stay was 45 (interquartile range: 43,47) hours. The observed mortality of 
2.6% compared favorably to the predicted mortality of 6.6%, as projected by 
EuroSCORE II. The list of comorbidities in our study cohort was representative of the 
contemporary cardiac surgical population. The baseline demographic and clinical profiles 
of the entire cohort, as well as the operative details, are presented in Table 1.  
 
3.2 Interchangeability of SvO2 and ScvO2 across the entire patient cohort 
The relationship between SvO2 and ScvO2 was inconsistent across the study period. 
Overall, the ScvO2 overestimated SvO2 by a mean bias of -1.2%. The 95% limits of 
agreement were wide (lower -14.2; upper 11,8; Figure 1A). The discrepancy between the 
SvO2 and ScvO2 was observed at all studied time points. Bland-Altman plots were 
constructed to illustrate the agreements between the SvO2 and ScvO2 at each individual 
data acquisition point. These are shown in Figure 1 (panels B, C and D).  
 
 
3.2. Correlation between the SvO2 and ScvO2 under different hemodynamic 
conditions  
Samples for 468 paired comparisons between SvO2 and ScvO2 from 156 patients were 
harvested at three different time points (T1, T2 and T3). One-hundred and one paired 
samples were obtained while the CI was less than or equal to 2.0 L/min/m
2 
at the time of 
data acquisition, while the remaining 367 paired samples were harvested under optimal 
hemodynamic settings (CI>2.0 L/min/m2). Since one patient provided 3 datasets (T1, T2 
and T3), the same patient could be represented with multiple paired samples but at 
different time-points and, consequently, with different hemodynamics.  Propensity scores 
were calculated, and then used to match data obtained from patients with a CI≤2.0 
L/min/m
2
 with samples harvested from patients with a CI>2.0 L/min/m
2
, in a 1:1 fashion. 
The final propensity-score matched analysis included 101 samples from 90 patients with 
a CI≤2.0 L/min/m2, and 101 samples from 84 patients with a CI>2.0 L/min/m2 at the time 
of sample acquisition. The calculated measures of cardiac performances (CI) in the 
propensity-score matched cohorts were 1.8±0.2 and 2.9±0.5 L/min/m
2
, respectively 
(P<0.001). There were no statistically significant differences between the studied 
subgroups in age, gender, operative risk, preoperative comorbidities, inotrope use and 
surgical complexity (all P>0.10). The correlations between SvO2 and ScvO2 were 
affected by the underlying cardiac performance (Figure 2). Central venous saturation 
exhibited a moderate-high level of correlation with SvO2 in patients with a cardiac output 
exceeding 2.0 L/min/m2 (Pearson’s r2=0.73). Within this propensity matched cohort of 
patients with a CI>2.0 L/min/m2, the mean bias was -1.6, while the upper and lower 
limits of agreement were -11.4% and 8.2%, respectively.  
The relationship between the SvO2 and ScvO2 among patients with a calculated cardiac 
index ≤2.0 L/min/m
2
, however, was much less robust (Pearson’s r
2
=0.37). While both 
correlation analyses revealed statistically significant relationships (P<0.01), the 
diagnostic accuracy of ScvO2 to predict SvO2 was clearly compromised in patients with 
inferior cardiac performance (Figure 2). This was further corroborated by wider 95% 
limits of agreement between SvO2 and ScvO2 in the propensity-score matched patients 
with a cardiac output ≤2.0 L/min/m2 (bias 0.08; lower limit: -14.2%; upper limit: 14.4%).  
 
3.3. Temporal changes in the SvO2–ScvO2 gradient 
In order to follow the trends in the differences between mixed venous and central 
saturations over the study period, patients were divided into tertiles based on the SvO2–
ScvO2 gradients obtained from the first paired blood samples (T0). The 33
rd
 and 66
th
 
percentile of the SvO2–ScvO2 gradient were -3% and +3%, respectively. The two 
aforementioned percentile boundaries were utilized to isolate patients into three groups 
(Table 2). Patients with an SvO2–ScvO2 gradient that was lower than -3% were 
considered to have a negative gradient, and were aggregated in group 1. Patients in whom 
the SvO2–ScvO2 differences were between -3% and +3% comprised the group 2, and 
were considered to have negligible gradients. Patients in whom the ScvO2 was greater 
than SvO2 by more than 3% were clustered in group 3, and were classified as having a 
positive SvO2–ScvO2 gradient.  
The same percentile boundaries were utilized for the duration of the data acquisition 
period. This allowed for observation of the SvO2–ScvO2 gradient trends across the study 
period. We found that the proportion of patients with a negative SvO2–ScvO2 gradient 
increased over time (48/156 (31%) at T0 to 73/156 (47%) at T2, P<0.01). Contrariwise, 
the number of patients with a positive SvO2–ScvO2 gradient decreased over the studied 
period (52/156 (33%) at T0 to 17/156 (11%). P<0.01). When evaluating the entire cohort 
including all 156 patients, we found that the SvO2–ScvO2 gradient widened toward 
incrementally more negative values over time (Figure 3). The SvO2–ScvO2 gradient was 
0.78±7.66 at T0, -1.44±6.4 at T1 and -2.89±5.07 at T2 (T0 vs. T1, P<0.01; T0 vs. T2, 
P<0.001; T1 vs. T2, P=0.12).  
 
3.4. Effects of clinical, operative and hemodynamic data on the SvO2–ScvO2 
gradient  
Cardiac performance according to data obtained from the PAC was consistently greater 
than 2.0 L/min/m
2
 in all three subgroups across the entire study period (Table 2). This is a 
reflection of our postoperative management strategy, which aimed at maintaining the 
cardiac index above 2.0 L/min/m2 in all patients. We, consequently, found no correlation 
between thermodilution cardiac indices and the SvO2–ScvO2 gradient when analyzing the 
entire pool of 468 paired samples (Pearson’s r
2
=-0.07, P=0.15). When evaluating the 
frequency of inotropic support utilization among the subgroups at T2, however, we found 
that patients with a positive SvO2–ScvO2 gradient were least likely to depend upon it for 
optimizing hemodynamics and also had lowest lactate levels (Table 2). Conversely, 
patients with a negative SvO2–ScvO2 gradient on postoperative day 1 had higher serum 
lactate levels (1.5±0.8 vs. 1.0±0.4 in group 3, P<0.01), mirroring the highest subgroup 
utilization of inotropic support (odds ratio 6.46 [95% CI 0.81 - 51.87], P=0.06). 
Additionally, these patients were older, came from the highest operative risk stratum, had 
longer CPB and myocardial ischemic times (Table 2). Patients with a negative SvO2–
ScvO2 gradient at T0 had lower stroke volume indices in comparison to patients with a 
positive SvO2–ScvO2 gradient (Table 2).  
  
  
4. Discussion 
 
The PAC has remained a commonly employed tool for optimizing the hemodynamic 
profile of cardiac surgical patients. PAC guided volume management is the subject of 
well-placed criticism. Intravascular pressure correlates poorly with intravascular volume 
[15], which is the only genuine equivalent of cardiac preload. Cardiac output 
measurements, however, can differentiate between various etiologies of postoperative 
hypotension. This distinction is paramount in guiding active therapy. While the 
information provided by the PAC may still hold value, multiple reports have been 
published since its inception cautioning its association with worse clinical outcomes 
[7,9,10]. Sandham et al found that PAC guided algorithms did not alter the outcomes in 
noncardiac surgical patients using a randomized controlled study design [12]. In the 
aftermath of these findings the use of PACs in the current medical and surgical practices 
has declined substantially [11]. The controversy on the efficacy of hemodynamic 
protocols, however, continues to be fueled by publications encapsulating their benefit in 
reducing mortality and postoperative organ dysfunction [13,14]. Additionally, SvO2 has 
been shown to predict postoperative mortality in patients following valvular surgery [16]. 
Even though risk adjustments for selection bias were performed in some of these 
conflicting studies, the rigors of large prospective randomized trials examining the role of 
right heart catheterization in cardiac surgical patients are sorely needed to definitively 
determine its role in modern practice [7].  
The ubiquitous utilization of central venous catheters in the ICU makes the temptation to 
substitute ScvO2 for SvO2 difficult to resist. Both mixed venous and central venous 
saturations are indicators of the balance between oxygen consumption and delivery 
[5,17]. Difficulties in interpreting ScvO2 are persuasively illustrated by the fact that 
values outside the normal range at either extreme, correlate with inferior outcomes [5].  
In our study, the relationship between ScvO2 and SvO2 was found to be inconsistent, 
thereby negating reliability in using the former parameter to estimate the latter. Our data 
is in line with similar observations in diverse clinical settings [8,17,18,19]. We also 
specifically investigated the impact of the underlying hemodynamic status on the 
interchangeability of ScvO2 and SvO2 by dichotomizing patients based on a cardiac index 
cut-off point of 2.0 L/min/m
2
. We found ScvO2 to be an increasingly less reliable 
substitute for SvO2 as the cardiac performance worsened. One may infer that during 
hypoperfusion, which is the very scenario when a less invasive marker of tissue 
oxygenation would be of greatest benefit, ScvO2 is also least effective in predicting SvO2. 
The wide limits of agreement across all comparisons between ScvO2 and SvO2 observed 
in our study parallel those seen in other publications [18,20,21] and reinforce the notion 
of a modest mutual association.  
The variability between the SvO2 and ScvO2 was evident at all studied time points in our 
study. The overall SvO2–ScvO2 gradient shifted from a slightly positive one 
preoperatively to increasingly more negative values over the ensuing data acquisition 
points. The proportion of patients with a negative SvO2–ScvO2 gradient increased from 
31% at T0 to 47% at T2. We found no correlation between the SvO2–ScvO2 gradient and 
hemodynamic data obtained from the PAC. One must recognize that we universally 
followed a goal-oriented strategy targeting a cardiac index of greater than 2.0 L/min/m
2
 
for the duration of hemodynamic monitoring. Active interventions to achieve that goal 
included volume replacement or inotropic support, as well as packed red blood cell 
transfusions aiming at increasing the oxygen carrying capacity. When considering the 
high postoperative inotrope utilization among patients with a negative SvO2–ScvO2 
gradient as a surrogate for a suboptimal hemodynamics, however, one may extrapolate 
that this subgroup had inferior pre-treatment cardiac indices. Gutierrez et al documented 
an association between a positive ScvO2–SvO2 gradient and survival in a cohort of 106 
critically ill patients [22]. The authors suggested that increasingly positive ScvO2–SvO2 
gradients reflected superior oxygen utilization [22]. While our study was larger in size 
than the aforementioned one, it was still underpowered to look at survival due to the 
excellent survival rates in the contemporary cardiac surgical practice. Our own data 
seemingly contradict the observations by Gutierrez and co-workes [22]. Patients in whom 
the central venous exceeded the mixed venous saturations (in our study denoted as a 
negative SvO2–ScvO2 gradient) had inferior indicators of their hemodynamic status. We 
believe that the reasons for this discrepancy lie in the multiple covariates that influence 
the saturation content within different venous pools, many of which cannot be reliably 
reproduced in dissimilar patient subpopulations. Primarily, the degree of cardiac oxygen 
utilization during and following hypothermic cardioplegic arrest remains unpredictable. 
Its assessment would require direct cannulation of the coronary sinus, which collects 
approximately 85% of coronary venous blood [23]. While this procedure is routinely 
performed in order to deliver retrograde cardioplegia, keeping the catheter in place 
beyond the period of aortic cross clamping for longitudinal sampling is potentially 
hazardous.  Moreover, the normally low oxygen extraction from the kidneys may 
increase in order to offset a reduction in blood flow that may occur during systemic 
hypoperfusion. Both of these events will only affect SvO2. Conversely, anesthesia and 
sedation reduce cerebral oxygen consumption [20], which will impact both SvO2 and 
ScvO2. All of the above mentioned issues consolidate the theoretical context of our 
observation that the individual variability between SvO2 and ScvO2 is erratic and 
unpredictable.  
The limitations of our study stem from its non-randomized design. The insertion of PACs 
in our practice is a part of the standard monitoring protocol, and is applied non-
selectively to all patients scheduled for cardiac surgery. Any bias in their application can, 
therefore, be excluded. More precise preload management in our practice could have 
been implemented with more liberal use of echocardiography. While echocardiography is 
implemented in the majority of patients intraoperatively, only a small fraction of them 
would have volumetric data available in the early postoperative period. We, therefore, 
rely on pressure recordings for optimizing volume management, understanding the 
inherent drawbacks of this strategy.   
  
5. Conclusions 
 
Our study confirms that ScvO2 is an unreliable substitute for SvO2 among patients 
undergoing cardiac surgery. The wide limits of agreement between these parameters at 
baseline are further amplified by hemodynamic compromise. Consequently, the accuracy 
of ScvO2 to predict SvO2 is lowest in patients in whom this information would potentially 
be of greatest benefit. Basing therapeutic decisions on ScvO2 based algorithms is, 
therefore, inappropriate in the cardiac surgical domain. Patients exhibiting negative 
SvO2-ScvO2 gradients postoperatively were more likely to require inotropic support for 
maintaining optimal hemodynamics. Furthermore, they were found to have a higher risk 
profile and higher serum lactates, as well as longer aortic cross-clamp and CPB times. 
 
 
  
Abbreviations  
 
ScvO2   central venous saturation 
SvO2   mixed venous saturation  
CPB   cardiopulmonary bypass  
CI   cardiac index  
PAC   pulmonary artery catheter  
ICU   intensive care unit  
IVC   inferior vena cava  
ECMO  extracorporeal membrane oxygenation  
 
  
Competing interests  
 
 
 
The authors declare that they have no competing interests. 
 
  
Authors’ contributions 
 
 
 
 HG participated in designing the study, performed the statistical analysis and drafted the 
manuscript. RG participated in designing the study, and revised the drafted manuscript for 
critically important content. ZO was responsible for acquisition of hemodynamic patient data, and 
helped draft the manuscript. TK was responsible for acquisition of clinical and operative patient 
data, and helped draft the manuscript. MP participated in performing the statistical analysis, and 
revised the drafted manuscript for critically important content. VI participated in designing the 
study, and revised the drafted manuscript for critically important content. BB provided general 
support, and revised the drafted manuscript for critically important content. All authors read and 
approved the final manuscript. 
 
  
References  
 
 
 
1. Vincent JL, Rhodes A, Perel A, Martin GS, Della Rocca G, Vallet B, et al. 
Clinical review: Update on hemodynamic monitoring--a consensus of 16. Crit 
Care 2011, 15(4):229 
2. Fuller BM, Dellinger RP. Lactate as a hemodynamic marker in the critically ill. 
Curr Opin Crit Care 2012, 18(3):267-72 
3. Ottervanger JP, Kruijssen HA, Hoes AW, Hofman A. Long-term prognostic 
importance of a single pulmonary wedge pressure measurement after myocardial 
infarction: a ten-year follow-up study. Int J Cardiol 1994, 43(3):239-46. 
4. Dreyer RP, Beltrame JF, Neil C, Air T, Tavella R, Hoffmann B, et al. Cardiac 
hemodynamics in men versus women during acute ST-segment elevation 
myocardial infarction. Am J Cardiol 2013, 112(2):143-9. 
5. Rajaram SS, Desai NK, Kalra A, Gajera M, Cavanaugh SK, Brampton W, et al.  
Pulmonary artery catheters for adult patients in intensive care. Cochrane Database 
Syst Rev 2013, doi: 10.1002/14651858.CD003408.pub3. 
6. Hadian M, Pinsky MR. Evidence-based review of the use of the pulmonary artery 
catheter: impact data and complications. Crit Care 2006, 10 (Suppl 3):S8. 
7. Schwann NM, Hillel Z, Hoeft A, Barash P, Möhnle P, Miao Y, et al. Lack of 
effectiveness of the pulmonary artery catheter in cardiac surgery. Anesth Analg 
2011, 113(5):994-1002.  
8. Chawla LS, Zia H, Gutierrez G, Katz NM, Seneff MG, Shah M. Lack of 
equivalence between central and mixed venous oxygen saturation. Chest 2004, 
126(6):1891-6. 
9. Connors AF Jr, Speroff T, Dawson NV, Thomas C, Harrell FE Jr, Wagner D, et 
al. The effectiveness of right heart catheterization in the initial care of critically ill 
patients. SUPPORT Investigators. JAMA 1996, 276(11):889-97. 
10. Figueiredo A, Germano N, Guedes P, Marcelino P. The evolving concepts of 
haemodynamic support: from pulmonary artery catheter to echocardiography and 
theragnostics. Curr Cardiol Rev 2011, 7(3):136-45. 
11. Wiener RS, Welch HG. Trends in the use of the pulmonary artery catheter in the 
United States, 1993-2004. JAMA 2007, 298(4):423-9. 
12. Sandham JD, Hull R, Brant RF, Knox L, Pineo GF, Doig CJ, et al; for the 
Canadian Critical Care Clinical Trials Group: A randomized, controlled trial of 
the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 
2003, 348(1):5-14. 
13. Gurgel ST, do Nascimento P Jr. Maintaining tissue perfusion in high-risk surgical 
patients: a systematic review of randomized clinical trials. Anesth Analg 2011, 
112(6):1384-91 
14. Hamilton MA, Cecconi M, Rhodes A. A systematic review and meta-analysis on 
the use of preemptive hemodynamic intervention to improve postoperative 
outcomes in moderate and high-risk surgical patients. Anesth Analg 2011, 
112(6):1392-402. 
15. Osman D, Ridel C, Ray P, Monnet X, Anguel N, Richard C, et al. Cardiac filling 
pressures are not appropriate to predict hemodynamic response to volume 
challenge. Crit Care Med 2007, 35(1):64-8. 
16. Holm J, Hakanson RE, Vánky F, Svedjeholm R. Mixed venous oxygen saturation 
is a prognostic marker after surgery for aortic stenosis. Acta Anaesthesiol Scand 
2010, 54(5):589-95. 
17. Yazigi A, El Khoury C, Jebara S, Haddad F, Hayeck G, Sleilaty G. Comparison 
of central venous to mixed venous oxygen saturation in patients with low cardiac 
index and filling pressures after coronary artery surgery. J Cardiothorac Vasc 
Anesth 2008, 22(1):77-83. 
18. van Beest PA, van Ingen J, Boerma EC, Holman ND, Groen H, Koopmans M, et 
al. No agreement of mixed venous and central venous saturation in sepsis, 
independent of sepsis origin. Crit Care 2010, 14(6):R219 
19. Lorentzen AG, Lindskov C, Sloth E, Jakobsen CJ. Central venous oxygen 
saturation cannot replace mixed venous saturation in patients undergoing cardiac 
surgery. J Cardiothorac Vasc Anesth 2008, 22(6):853-7 
20. Sander M, Spies CD, Foer A, Weymann L, Braun J, Volk T, et al. Agreement of 
central venous saturation and mixed venous saturation in cardiac surgery patients. 
Intensive Care Med 2007, 33(10):1719-25. 
21. Varpula M, Karlsson S, Ruokonen E, Pettilä V. Mixed venous oxygen saturation 
cannot be estimated by central venous oxygen saturation in septic shock. Intensive 
Care Med 2006, 32(9):1336-43. 
22. Gutierrez G, Comignani P, Huespe L, Hurtado FJ, Dubin A, Jha V, et al.  Central 
venous to mixed venous blood oxygen and lactate gradients are associated with 
outcome in critically ill patients. Intensive Care Med 2008, 34(9):1662-8. 
23. Mill MR, Wilcox BR, Anderson RH: Surgical anatomy of the heart. In Cardiac 
Surgery in the Adult. 2nd Edition. Edited by Cohn LH, Edmunds LH, Jr. New 
York: McGraw-Hill; 2003:31-52 
 
  
Figure 1. Bland-Altman plot showing the agreements between ScvO2 and SvO2 within the 
entire sample (Panel A; mean bias -1.2, 95% limits of agreement from -14.2 to 11.8), at 
T0 (Panel B; mean bias 0.8, 95% limits of agreement from -14.2 to 15.8), T1 (Panel C; 
mean bias -1.4, 95% limits of agreement from -14.0 to 11.1), and T2 (Panel D; mean bias 
-2.9, 95% limits of agreement from -12.8 to 7.0)  
 
 
Figure 2. Correlation between SvO2 and ScvO2 during optimal hemodynamic settings 
(CI>2.0 L/min/m
2
) shows a moderate-high correlation coefficient (Panel A). Low level of 
correlation between SvO2 and ScvO2 is seen when CI≤2.0 L/min/m
2 
(Panel B). 
SvO2, mixed venous saturation; ScvO2, central venous saturation; CI, cardiac index 
 
 
Figure 3. Box-and-whisker plot depicting the progressive rise in the SvO2–ScvO2 
gradient over the data acquisition period 
 
Table 1. Baseline demographic, clinical and operative data 
 
All patients (N=156) 
Preoperative patient characteristics   
Age, y 65±10 
Male, n (%) 106 (68) 
EuroSCORE II 6.6±11.0 
Body mass index, kg/m
2
 28±5 
LVEF, % 53±14 
Hyperlipidemia, n (%) 79 (51) 
Diabetes mellitus n (%) 40 (26) 
Smoking history, n (%) 23 (15) 
Chronic obstructive pulmonary disease. n (%) 15 (10) 
Hypertension, n (%) 129 (83) 
History of AMI, n (%) 41 (26) 
Renal impairment 13 (8) 
Preoperative medications, n (%) 
 
Clopidogrel 34 (22) 
Aspirin 116 (74) 
Beta blocker 100 (64) 
Angiotensin-converting enzyme inhibitor 113 (72) 
Statin 107 (69) 
Perioperative data, n (%) 
 
Isolated CABG 68 (44) 
Isolated valve surgery 55 (35) 
CABG plus valve surgery 21 (13) 
Valve plus aortic surgery 12 (8) 
CPB, min 115±58 
Aortic cross clamp time, min 81±40 
Intensive care unit stay (hours; median, IQR) 45 [43,47] 
Stroke 2 (1) 
Renal failure requiring RRT 2 (1) 
Perioperative AMI 7 (4) 
30-day mortality 4 (3) 
 
LVEF, Left ventricular ejection fraction; AMI, acute myocardial infarction; CABG, coronary artery bypass 
surgery; CPB, cardiopulmonary bypass; IQR, interquartile range; RRT, renal replacement therapy 
 
 
